FDA approves Joenja (leniolisib) for APDS in children 4-11
The FDA approved Joenja (leniolisib) as the first treatment for APDS in children aged 4-11.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.